[Peculiarities in the treatment of systemic mycoses].
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008825:Miconazole / Q000627:therapeutic use; D010229:Paracoccidioidomycosis / Q000188:drug therapy*; D013424:Sulfanilamides / Q000627:therapeutic use*
D000935:Antifungal Agents; D013424:Sulfanilamides; D008825:Miconazole; D000666:Amphotericin B; D005437:Flucytosine; D007654:Ketoconazole
Peculiaridades na terapêutica das micoses sistêmicas.